Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Cambrex Corporation
Aevi needs to raise funds first, but hopes to develop MEDI2338 for adult-onset Still’s disease. Also, Alnylam plans to leverage Ironwood’s GI expertise for givosiran in acute hepatic porphyria and Ultragenyx snags option to buy GeneTx.
Stada has turned to the FMCG world to find a head for its German operations, while former FDA commissioner Scott Gottlieb has linked up with Pfizer, and Nippon Kayaku has a new pharma head.
Court overrides stem cell clinic’s dismissal of drug GMPs, the US FDA upbraids drug makers for quality unit shortfalls, and a variety of snafus trigger drug recalls.
Sterling Pharma Solutions has acquired a US facility and Olon has bought a plant from Sandoz, while Normon is investing €100m in manufacturing expansions.
- Contract Research, Toxicology Testing-CRO
- Other Names / Subsidiaries
- Avista Pharma Solutions
- Halo Pharma
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.